{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:32:52Z","timestamp":1792290772900,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02729"],"award-info":[{"award-number":["18H02729"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15J00397"],"award-info":[{"award-number":["15J00397"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12012-021-09718-2","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:04:41Z","timestamp":1643328281000},"page":"365-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy"],"prefix":"10.1007","volume":"22","author":[{"given":"Kazutoshi","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimaiti","family":"Yisireyili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumie","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian Wu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-3799","authenticated-orcid":false,"given":"Kyosuke","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"9718_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lfs.2017.07.027","volume":"185","author":"H Gao","year":"2017","unstructured":"Gao, H., & Liu, S. (2017). Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Life Sciences, 185, 23\u201329.","journal-title":"Life Sciences"},{"key":"9718_CR2","first-page":"1","volume":"72","author":"T Niwa","year":"2010","unstructured":"Niwa, T. (2010). Uremic toxicity of indoxyl sulfate. Nagoya Journal of Medical Science, 72, 1\u201311.","journal-title":"Nagoya Journal of Medical Science"},{"key":"9718_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.amjcard.2012.11.025","volume":"111","author":"B Sato","year":"2013","unstructured":"Sato, B., Yoshikawa, D., Ishii, H., Suzuki, S., Inoue, Y., Takeshita, K., Tanaka, M., Kumagai, S., Matsumoto, M., Okumura, S., Hayashi, M., Matsubara, T., Niwa, T., & Murohara, T. (2013). Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction. The American Journal of Cardiology, 111, 712\u2013716.","journal-title":"The American Journal of Cardiology"},{"key":"9718_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1253\/circj.CJ-12-0715","volume":"77","author":"S Shimazu","year":"2013","unstructured":"Shimazu, S., Hirashiki, A., Okumura, T., Yamada, T., Okamoto, R., Shinoda, N., Takeshita, K., Kondo, T., Niwa, T., & Murohara, T. (2013). Association between indoxyl sulfate and cardiac dysfunction and prognosis in patients with dilated cardiomyopathy. Circulation Journal: Official journal of the Japanese Circulation Society, 77, 390\u2013396.","journal-title":"Circulation Journal: Official journal of the Japanese Circulation Society"},{"key":"9718_CR5","doi-asserted-by":"publisher","first-page":"e109268","DOI":"10.1371\/journal.pone.0109268","volume":"9","author":"M Yisireyili","year":"2014","unstructured":"Yisireyili, M., Saito, S., Abudureyimu, S., Adelibieke, Y., Ng, H. Y., Nishijima, F., Takeshita, K., Murohara, T., & Niwa, T. (2014). Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS ONE, 9, e109268.","journal-title":"PLoS ONE"},{"key":"9718_CR6","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3389\/fimmu.2019.01592","volume":"10","author":"N An","year":"2019","unstructured":"An, N., Gao, Y., Si, Z., Zhang, H., Wang, L., Tian, C., Yuan, M., Yang, X., Li, X., Shang, H., Xiong, X., & Xing, Y. (2019). Regulatory mechanisms of the NLRP3 inflammasome, a novel immune-inflammatory marker in cardiovascular diseases. Frontiers in Immunology, 10, 1592.","journal-title":"Frontiers in Immunology"},{"key":"9718_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","volume":"113","author":"D Liu","year":"2018","unstructured":"Liu, D., Zeng, X., Li, X., Mehta, J. L., & Wang, X. (2018). Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Research in Cardiology, 113, 5.","journal-title":"Basic Research in Cardiology"},{"key":"9718_CR8","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019). Pharmacological inhibitors of the NLRP3 inflammasome. Frontiers in Immunology, 10, 2538.","journal-title":"Frontiers in Immunology"},{"key":"9718_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41401-019-0305-x","volume":"41","author":"JZ Xin","year":"2020","unstructured":"Xin, J. Z., Wu, J. M., Hu, G. M., Gu, H. J., Feng, Y. N., Wang, S. X., Cong, W. W., Li, M. Z., Xu, W. L., Song, Y., Xiao, H., Zhang, Y. Y., & Wang, L. (2020). alpha1-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation. Acta Pharmacologica Sinica, 41, 311\u2013318.","journal-title":"Acta Pharmacologica Sinica"},{"key":"9718_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/toxins12030161","volume":"12","author":"N Kaesler","year":"2020","unstructured":"Kaesler, N., Babler, A., Floege, J., & Kramann, R. (2020). Cardiac remodeling in chronic kidney disease. Toxins, 12, 161.","journal-title":"Toxins"},{"key":"9718_CR11","first-page":"477","volume":"79","author":"M Yisireyili","year":"2017","unstructured":"Yisireyili, M., Takeshita, K., Saito, S., Murohara, T., & Niwa, T. (2017). Indole-3-propionic acid suppresses indoxyl sulfate-induced expression of fibrotic and inflammatory genes in proximal tubular cells. Nagoya Journal of Medical Science, 79, 477\u2013486.","journal-title":"Nagoya Journal of Medical Science"},{"key":"9718_CR12","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijms.43184","volume":"17","author":"K Yamaguchi","year":"2020","unstructured":"Yamaguchi, K., Yisireyili, M., Goto, S., Kato, K., Cheng, X. W., Nakayama, T., Matsushita, T., Niwa, T., Murohara, T., & Takeshita, K. (2020). Indoxyl Sulfate-induced vascular calcification is mediated through altered notch signaling pathway in vascular smooth muscle cells. International Journal of Medical Sciences, 17, 2703\u20132717.","journal-title":"International Journal of Medical Sciences"},{"key":"9718_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0002-9440(10)63135-5","volume":"164","author":"K Takeshita","year":"2004","unstructured":"Takeshita, K., Hayashi, M., Iino, S., Kondo, T., Inden, Y., Iwase, M., Kojima, T., Hirai, M., Ito, M., Loskutoff, D. J., Saito, H., Murohara, T., & Yamamoto, K. (2004). Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction. The American Journal of Pathology, 164, 449\u2013456.","journal-title":"The American Journal of Pathology"},{"key":"9718_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.psyneuen.2016.08.004","volume":"73","author":"M Yisireyili","year":"2016","unstructured":"Yisireyili, M., Takeshita, K., Hayashi, M., Wu, H., Uchida, Y., Yamamoto, K., Kikuchi, R., Hao, C. N., Nakayama, T., Cheng, X. W., Matsushita, T., Nakamura, S., & Murohara, T. (2016). Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model. Psychoneuroendocrinology, 73, 186\u2013195.","journal-title":"Psychoneuroendocrinology"},{"key":"9718_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/labinvest.2011.5","volume":"91","author":"R Kikuchi","year":"2011","unstructured":"Kikuchi, R., Takeshita, K., Uchida, Y., Kondo, M., Cheng, X. W., Nakayama, T., Yamamoto, K., Matsushita, T., Liao, J. K., & Murohara, T. (2011). Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF. Laboratory Investigation, 91, 691\u2013703.","journal-title":"Laboratory Investigation"},{"key":"9718_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","volume":"12","author":"JC Schefold","year":"2016","unstructured":"Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D., & von Haehling, S. (2016). Heart failure and kidney dysfunction: Epidemiology, mechanisms and management. Nature Reviews. Nephrology, 12, 610\u2013623.","journal-title":"Nature Reviews. Nephrology"},{"key":"9718_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.7150\/ijms.32629","volume":"16","author":"K Furusawa","year":"2019","unstructured":"Furusawa, K., Takeshita, K., Suzuki, S., Tatami, Y., Morimoto, R., Okumura, T., Yasuda, Y., & Murohara, T. (2019). Assessment of abdominal aortic calcification by computed tomography for prediction of latent left ventricular stiffness and future cardiovascular risk in pre-dialysis patients with chronic kidney disease: A single center cross-sectional study. International Journal of Medical Sciences, 16, 939\u2013948.","journal-title":"International Journal of Medical Sciences"},{"key":"9718_CR18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3109\/0886022X.2015.1061669","volume":"37","author":"A Pluta","year":"2015","unstructured":"Pluta, A., Strozecki, P., Krintus, M., Odrowaz-Sypniewska, G., & Manitius, J. (2015). Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1\u20133. Renal Failure, 37, 1105\u20131110.","journal-title":"Renal Failure"},{"key":"9718_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ki.2008.690","volume":"75","author":"AM Siedlecki","year":"2009","unstructured":"Siedlecki, A. M., Jin, X., & Muslin, A. J. (2009). Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney International, 75, 800\u2013808.","journal-title":"Kidney International"},{"key":"9718_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.lfs.2013.05.008","volume":"92","author":"M Yisireyili","year":"2013","unstructured":"Yisireyili, M., Shimizu, H., Saito, S., Enomoto, A., Nishijima, F., & Niwa, T. (2013). Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. Life Sciences, 92, 1180\u20131185.","journal-title":"Life Sciences"},{"key":"9718_CR21","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00204-019-02446-1","volume":"93","author":"S Ichihara","year":"2019","unstructured":"Ichihara, S., Li, P., Mise, N., Suzuki, Y., Izuoka, K., Nakajima, T., Gonzalez, F., & Ichihara, G. (2019). Ablation of aryl hydrocarbon receptor promotes angiotensin II-induced cardiac fibrosis through enhanced c-Jun\/HIF-1alpha signaling. Archives of Toxicology, 93, 1543\u20131553.","journal-title":"Archives of Toxicology"},{"key":"9718_CR22","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1128\/IAI.00575-16","volume":"84","author":"A Barroso","year":"2016","unstructured":"Barroso, A., Gualdron-Lopez, M., Esper, L., Brant, F., Araujo, R. R., Carneiro, M. B., Avila, T. V., Souza, D. G., Vieira, L. Q., Rachid, M. A., Tanowitz, H. B., Teixeira, M. M., & Machado, F. S. (2016). The aryl hydrocarbon receptor modulates production of cytokines and reactive oxygen species and development of myocarditis during Trypanosoma cruzi infection. Infection and Immunity, 84, 3071\u20133082.","journal-title":"Infection and Immunity"},{"key":"9718_CR23","doi-asserted-by":"publisher","first-page":"652097","DOI":"10.1155\/2011\/652097","volume":"2011","author":"O Lorenzo","year":"2011","unstructured":"Lorenzo, O., Picatoste, B., Ares-Carrasco, S., Ramirez, E., Egido, J., & Tunon, J. (2011). Potential role of nuclear factor kappaB in diabetic cardiomyopathy. Mediators of Inflammation, 2011, 652097.","journal-title":"Mediators of Inflammation"},{"key":"9718_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M., & Sasakawa, C. (2016). Molecular mechanisms regulating NLRP3 inflammasome activation. Cellular & Molecular Immunology, 13, 148\u2013159.","journal-title":"Cellular & Molecular Immunology"},{"key":"9718_CR25","doi-asserted-by":"publisher","first-page":"8087","DOI":"10.3390\/ijms21218087","volume":"21","author":"M Cornut","year":"2020","unstructured":"Cornut, M., Bourdonnay, E., & Henry, T. (2020). Transcriptional regulation of inflammasomes. International Journal of Molecular Sciences, 21, 8087.","journal-title":"International Journal of Molecular Sciences"},{"key":"9718_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jacbts.2020.03.015","volume":"5","author":"RI Jaen","year":"2020","unstructured":"Jaen, R. I., Val-Blasco, A., Prieto, P., Gil-Fernandez, M., Smani, T., Lopez-Sendon, J. L., Delgado, C., Bosca, L., & Fernandez-Velasco, M. (2020). Innate immune receptors, key actors in cardiovascular diseases. JACC. Basic to Translational Science, 5, 735\u2013749.","journal-title":"JACC. Basic to Translational Science"},{"key":"9718_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011). Transforming growth factor (TGF)-beta signaling in cardiac remodeling. Journal of Molecular and Cellular Cardiology, 51, 600\u2013606.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9718_CR28","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.2174\/13816128113199990449","volume":"20","author":"M Cavalera","year":"2014","unstructured":"Cavalera, M., & Frangogiannis, N. G. (2014). Targeting the chemokines in cardiac repair. Current Pharmaceutical Design, 20, 1971\u20131979.","journal-title":"Current Pharmaceutical Design"},{"key":"9718_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jacc.2011.06.058","volume":"58","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez, A., Ravassa, S., Beaumont, J., Lopez, B., & Diez, J. (2011). New targets to treat the structural remodeling of the myocardium. Journal of the American College of Cardiology, 58, 1833\u20131843.","journal-title":"Journal of the American College of Cardiology"},{"key":"9718_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2353\/ajpath.2007.061078","volume":"171","author":"B Coles","year":"2007","unstructured":"Coles, B., Fielding, C. A., Rose-John, S., Scheller, J., Jones, S. A., & O\u2019Donnell, V. B. (2007). Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. The American Journal of Pathology, 171, 315\u2013325.","journal-title":"The American Journal of Pathology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-021-09718-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T12:16:24Z","timestamp":1646828184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-021-09718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["9718"],"URL":"https:\/\/doi.org\/10.1007\/s12012-021-09718-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Financial interests: S.G. is employed by Kureha Co. Kureha Co had no role in the design of the study, collection, analysis, and interpretation of data, in the writing of the manuscript, or in the decision to publish the results. Non-financial interests: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Animal Care Committee of Kureha Biomedical Research Laboratories approved the animal studies described here (IRB Approval No.: A15-081). All experiments were conducted according to the Guiding Principles for the Care and Use of Laboratory Animals of the Japanese Pharmacological Society.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}